月度归档： 2026 年 1 月

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – As China’s first batch of Level 3 (L3) conditionally autonomous driving vehicles receives official market access, advanced smart driving is poised for its inaugural year of commercial explosion. At this pivotal juncture, Cheche Group Inc. (CCG) ("Cheche" or the "Company"), a leading global InsurTech platform, announced the signing of a strategic cooperation agreement with Volkswagen (Anhui) Digital Sales and Services Co., Ltd. (hereinafter "DSSO") and Beijing Cardif Airstar Property & Casualty Insurance Co., Ltd. (hereinafter "Cardif Airstar Insurance").This tripartite collaboration is more than just a deep dive into high-quality growth for New Energy Vehicle (NEV) insurance; it represents a core transition from "digitization" to "intelligence." The partnership establishes three strategic directions for synergy. First, it focuses on the transformation of product formats by leveraging Cheche’s SaaS platform to co-create an integrated "Insurance + Value-Added Services" package, enabling the efficient, one-stop fulfillment of high-value services. Second, it upgrades pricing capabilities by deeply integrating compliant driving data with dynamic vehicle information, utilizing AI-driven risk profiling to achieve differentiated precision pricing while addressing the complex challenge of liability determination in human-machine co-driving scenarios. Finally, it expands the ecosystem dimension by embedding insurance services throughout the vehicle sales and after-sales process, extending the business from a single policy to a full-lifecycle service ecosystem that encompasses renewal management and mobility protection.01. Smart Driving Insurance: Securing "Pricing Authority" in the L3 Mass Production EraTraditional auto insurance has long struggled with "human-machine co-driving" scenarios due to a lack of real-time dynamic data for liability determination and precise risk identification. Having served leading automakers such as Tesla, Li Auto, and Xiaomi, Cheche provides VW Anhui Digital with an embedded SaaS system centered on data attribution and dynamic pricing.Through this SaaS infrastructure, vehicle driving data is seamlessly synchronized with BNP Paribas Star’s actuarial models. This AI-driven joint risk profiling not only resolves the technical difficulties of liability judgment in smart driving scenarios but also delivers a "low-premium rewards for safe drivers," serving as a vital solution to the profitability challenges currently facing the NEV insurance industry.02. Ecosystem Breakthrough: Leveraging the "Xiaomi + Volkswagen DSSO" New Quality Productive ForcesInvestors are closely watching the cross-sector dynamics underpinning this collaboration. Cardif Airstar Insurance was co-founded by Xiaomi Group, Volkswagen Financial Services, and Cardif Airstar Insurance, combining the strengths of an internet giant, a global financial powerhouse, and a leading smart automaker.As the hub connecting these forces with Volkswagen’s Hefei Intelligent Electric Vehicle Center, Cheche is penetrating the world’s top smart driving supply chains. This is not merely system integration; it marks Cheche’s evolution into a digital operator within the "Vehicle-Battery-Charging-Insurance" integrated landscape. Amid policy tailwinds such as "New Quality Productive Forces," Cheche’s closed-loop ecosystem is becoming a definitive growth pole for insurance and tech capital.03. Scenario Transformation: From Transactional Policies to Full-Lifecycle OperationsIn 2026, as the automotive market shifts from a competition over hardware parameters to a competition over user experience, Cheche is helping DSSO deeply couple insurance services with the car-buying and after-sales journey. The integrated service package transforms insurance from a low-frequency tool into a high-frequency touchpoint for user engagement.Christian Koenig, After-sales Director of DSSO, noted that Cheche’s technical foundation allowed the partnership to advance rapidly from a high starting point. This "plug-and-play" empowerment capability, proven by mainstream automakers, has become a technical moat for Cheche in the capital markets.04. Conclusion: The Final Piece of the Trillion-Dollar Blue OceanThe year 2026 marks the point where NEV insurance evolves from scale expansion to intelligent upgrades. Cheche will continue to advance its AI pricing engine, driving the leap from digital to intelligent services.According to data released by the Ministry of Public Security on January 26, China’s NEV ownership reached 43.97 million units by the end of 2025, accounting for 12.01% of the total vehicle population—a growth rate exceeding 40% year-over-year. In this environment, those who define the insurance standards for the smart driving era will control the entry point to future mobility. With its high barriers to entry via OEM partnerships and forward-looking AI layouts, Cheche is racing toward becoming a leader in the trillion-dollar NEV insurance market. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – 27 January 2026, Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) announced its continued support for elite athletes from The Education University of Hong Kong (“EdUHK”) for the fourth consecutive year. The Presentation Ceremony for the Nissin Foods Scholarship for Elite Athletes 2025/2026 was held to honour seven outstanding athletes who not only demonstrate excellence in their respective sports but also aspire to become future educators. The scholarship will cover their full tuition fees throughout their entire study period, enabling them to pursue their academic and athletic goals without financial concerns.Established in 2022 by the Nissin Foods (Hong Kong) Charity Fund, the scholarship is designed to encourage elite athletes enrolled in the Bachelor of Health Education (Honours), Bachelor of Science (Honours) in Sports Science and Coaching, or the Postgraduate Diploma in Education programme at EdUHK. The initiative aims to support their dual career development, empowering them to become qualified health educators while continuing to strive for excellence in their athletic performance.The seven awardees for the 2025/2026 academic year include new and renewing recipients. The four new awardees are: Mr. MOK Pak Fan (triathlon), Mr. WONG Pak Yiu (triathlon), Miss HO Kin Yiu (volleyball), and Miss YAN Nuo (shuttlecock). In addition to welcoming new scholars, the Charity Fund also made the scholarship renewable to support the elite athletes throughout their study period. The three recipients of the renewed scholarship are: Mr. CHOI Kwan Lok (cycling, retired), Mr. CHEN Pak Hong (rowing), and Mr. Joseph LAU (cycling).Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund, said, “Having been deeply rooted in Hong Kong for over four decades, Nissin Foods is steadfast in its mission to give back to the community. This scholarship is a direct reflection of our founder Mr. Momofuku Ando’s philosophy that ‘Eating and sports are the two axles of health.’ By supporting these talented athletes at EdUHK for the fourth year, we are not just providing financial support, we are investing in future leaders who will champion health and wellness in our society. We are proud to empower them on their dual career path, confident that they will inspire the next generation as both accomplished athletes and dedicated educators.”Expressing his profound gratitude for the long-standing partnership, Professor Chetwyn CHAN, Vice President (Research and Development) of EdUHK, said, “EdUHK is dedicated to promoting sustainable dual-career pathways for high-performance athletes. The generous Nissin Foods Scholarship for Elite Athletes allows us to support both active and retired athletes in advancing their educational pursuits, while also recognising their exceptional sporting accomplishments. I would like to extend my heartfelt congratulations to all the scholarship recipients, who demonstrated great passion, determination, and a sense of mission, and sincerely thank the Nissin Foods (Hong Kong) Charity Fund, and Mr Ando for the tremendous support and confidence in health education and the development of elite athletes.”Accomplished volleyball player Miss HO Kin Yiu, recipient of the scholarship from the Postgraduate Diploma in Education, majoring in Chinese and Physical Education, shared her heartfelt appreciation to the Charity Fund, “The support of the scholarship empowers us, as elite athlete-students, to chase our aspirations and make a meaningful influence on society. We are confident that we can help create a brighter future through the spirit of sports and education.”PhotoMr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund (middle right), and Professor Chetwyn CHAN, Vice President (Research and Development) of EdUHK (middle left), attended the Presentation Ceremony for Nissin Foods Scholarship for Elite Athletes 2025/2026 on 27 January 2026. Five scholarship recipients attended the ceremony, including four new awardees for the 2025/2026 academic year, namely: (from left to right) Mr. MOK Pak Fan, Mr. WONG Pak Yiu, Miss HO Kin Yiu, and Miss YAN Nuo, as well as the renewed awardee - Mr. CHOI Kwan Lok. Awardees of the Nissin Foods Scholarship for Elite Athletes 2025/2026 are achieving great success in their individual disciplines. From top left: Mr. WONG Pak Yiu (triathlon), Miss HO Kin Yiu (volleyball), Mr. MOK Pak Fan (triathlon), Miss YAN Nuo (shuttlecock), Mr. CHOI Kwan Lok (cycling, retired), Mr. CHEN Pak Hong (rowing), and Mr. Joseph LAU (cycling).About Nissin Foods (Hong Kong) Charity FundThe Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475). The objectives of the Charity Fund are: a) to advance education, teaching, learning, arts, science and academic research; b) to make provision for people in need; and c) to carry out works of a charitable nature that are beneficial to the Hong Kong community. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

深圳, 2026年1月30日 - (亚太商讯 via SeaPRwire.com) - 康哲药业控股有限公司 （"康哲药业"）欣然宣布，旗下德镁医药有限公司（"德镁医药"，专业聚焦皮肤健康的创新型医药企业，正申请于香港联合交易所有限公司主板独立上市，详见康哲药业日期为2025年4月22日发布的公告）已于2026年1月30日获得中国国家药品监督管理局（NMPA）批准磷酸芦可替尼乳膏（白癜风适应症）（"产品"）新药上市许可申请（NDA）。产品用于治疗12岁及以上儿童和成人患者伴面部受累的非节段型白癜风，是中国批准的首款且唯一用于白癜风治疗的靶向药，满足巨大未被满足的临床需求。磷酸芦可替尼乳膏是经美国食品和药物管理局（FDA）及欧洲药品管理局（EMA）批准的首款也是唯一一款用于非节段型白癜风复色的药物[1,2]，在产品正式获得NDA批准之前，康哲药业受益于国家赋予海南自由贸易港及乐城先行区（"乐城先行区"）"先行先试"政策、"港澳药械通"政策、北京市及天津自贸试验区的临床急需进口药品政策，已启动磷酸芦可替尼乳膏的试点应用。目前博鳌超级医院已为超7,000名非节段型白癜风患者开具磷酸芦可替尼乳膏处方，且广州、深圳、东莞、佛山、中山、珠海、江门、惠州、北京及天津共二十余家医院已提供该药品处方服务，体现了其临床价值。产品在境外临床研究与中国真实世界研究中均展现出积极结果：其在境外开展的两项相同设计的III期双盲、随机、安慰剂对照研究（TRuE-V1和TRuE-V2）中，产品治疗24周后达到主要疗效指标面部白癜风面积评分指数改善至少75%（F-VASI 75）的患者比例均为29.9%，显著高于安慰剂组的7.5%和12.9%，持续使用至52周，复色效果持续[3]。根据乐城先行区药品真实世界数据应用试点项目有关规定，磷酸芦可替尼乳膏在中国开展真实世界研究，疗效积极，与境外关键临床研究结果一致。境内外临床研究中所有的次要疗效指标均显示出与主要疗效指标一致的获益趋势，且白癜风治疗效果随疗程延长持续改善。同时，根据乐城先行区安全性监测数据，未发现新的安全性事件，未发生导致停药或退出的不良事件（AE），未发生研究药物相关的严重不良事件（SAE）。此次产品白癜风适应症获批，将为国内千万白癜风患者带来治疗新希望，满足市场迫切的临床需求。同时，产品将进一步丰富德镁医药在皮肤治疗领域的产品矩阵，并有望与现有处于商业化阶段的创新药益路取（替瑞奇珠单抗注射液）、独家药喜辽妥（多磺酸粘多糖乳膏），以及系列在研创新药和皮肤学级护肤品等在专家网络与市场资源等方面产生协同，提升德镁医药在皮肤健康领域的地位。此外，康哲药业于中国开展的磷酸芦可替尼乳膏治疗轻中度特应性皮炎患者的III期临床试验，已取得阳性结果。截至目前，康哲药业正在中国积极推进磷酸芦可替尼乳膏治疗特应性皮炎的新药上市申请，如若获批上市，将为中国广大特应性皮炎患者群体提供新的治疗选择。关于白癜风适应症白癜风是一种慢性自身免疫性疾病，其特征是皮肤色素脱失，其发病原因为产生色素的细胞即黑素细胞的缺失。据估算，中国约有1030万人患有白癜风，其中约820万人患有非节段型白癜风[4]。现有疗法，如外用糖皮质激素（TCS）及外用钙调神经磷酸酶抑制剂（TCIs）存在临床缺陷，长期用药有不良反应或疗效有限。磷酸芦可替尼乳膏NDA获批，成功填补了白癜风靶向药物治疗的空白，具有重大标志性意义。关于磷酸芦可替尼乳膏的更多信息磷酸芦可替尼乳膏（Opzelura®）是Incyte开发的选择性JAK1/JAK2抑制剂芦可替尼制成的一种创新型乳膏，在美国获批用于局部治疗成人及12岁及以上患者的非节段型白癜风，及2岁及以上非免疫力功能低下患者的轻度至中度特应性皮炎的局部短期和非连续性慢性治疗。在欧洲，磷酸芦可替尼乳膏被批准用于治疗成年及12岁及以上青少年面部受累的非节段型白癜风。康哲药业于2022年12月2日，通过德镁医药的附属公司与Incyte就磷酸芦可替尼乳膏订立合作和许可协议（"许可协议"），获得在中国大陆、香港特别行政区、澳门特别行政区、台湾地区及东南亚十一囯（"区域"）研发、注册及商业化产品的独家许可权利，以及在区域内生产产品的非独家许可权利。德镁医药的附属公司已将磷酸芦可替尼乳膏除中国大陆外的其他区域的相关权利再许可予康哲药业（不包括德镁医药及其附属公司）。Incyte拥有磷酸芦可替尼乳膏全球开发和商业化权利，在美国及欧洲以Opzelura®的名称销售。Opzelura®和Opzelura®标识是Incyte的注册商标。关于康哲药业康哲药业是一家链接医药创新与商业化，把控产品全生命周期管理的开放式平台型企业，致力于提供有竞争力的产品和服务，满足尚未满足的医疗需求。康哲药业专注于全球首创（FIC）及同类最优（BIC）的创新产品，并高效推进创新产品临床研究开发和商业化进程，赋能科研成果向诊疗实践的持续转化，造福患者。康哲药业聚焦专科领域，拥有被验证的商业化能力，广泛的渠道覆盖和多疾病领域专家资源，核心在售产品已获领先的学术与市场地位。康哲药业围绕优势专科领域不断纵深发展，以巩固心脑血管/消化/眼科/皮肤健康业务竞争力，带来专科规模效率，其中皮肤健康业务（德镁医药）已成为其细分领域的龙头企业，并拟于联交所独立上市。同时，康哲药业持续推动研产销全产业链在东南亚及中东区域运营发展，以获取新兴市场的增量，助力集团实现高质量可持续发展。参考文献/资料1.FDA批准信息可在Incyte官网查询，网址：https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream2.EMA批准信息可在Incyte官网查询，网址：https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar3.相关临床研究信息可在Opzelura®官网查询，网址：https://www.opzelura.com/opzelura-prescribing-information4.数据来自灼识咨询报告康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广，非广告用途。本新闻不对任何药品和-医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息，请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请，不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制，但康哲药业并无进行任何说明或保证、明述或暗示，或其他表述，对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述，该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证，存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测，康哲药业对该等第三方声明及预测不承担责任。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

PUTNAM, CT AND ROMEOVILLE, IL, Jan 29, 2026 - (ACN Newswire via SeaPRwire.com) - Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials."Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications."Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.Key DetailsFormerra will distribute Foster® medical compounds in Europe.This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.About GEON Performance SolutionsGEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.Media ContactJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – A growing number of robotics and artificial intelligence companies backed by Shoucheng Holdings Limited are set to appear at China’s 2026 CMG New Year’s Gala, reflecting the investor’s expanding footprint across the country’s emerging automation and embodied intelligence sectors.The latest company to confirm its participation is Noetix Robotics, according to recent announcements. Shoucheng Holdings led the company’s financing round in 2024 and has continued to increase its investment through subsequent rounds, making it Noetix Robotics’ largest external investor, people familiar with the matter said.Noetix Robotics’ appearance adds to a lineup that already includes other Shoucheng-backed firms. Unitree Robotics, known for its quadruped and humanoid robots, was earlier named a robot partner of the 2026 Gala, marking its third appearance on the program. Beijing Galbot Co., Ltd., which focuses on embodied artificial intelligence systems, has also been designated by China Media Group as the Gala’s embodied large-model robot.The clustering of multiple portfolio companies on the same edition of the Gala places Shoucheng Holdings among a small group of investors with broad representation on one of China’s most-watched annual broadcasts. The event, which regularly draws hundreds of millions of viewers, has increasingly been used as a platform to highlight advances in artificial intelligence, robotics and advanced manufacturing.China Media Group, the organizer of the Gala, has in recent years expanded the role of technology-focused programming, aligning with national policy priorities around intelligent manufacturing and industrial upgrading. While participation in the Gala does not directly translate into revenue, companies and investors see it as an important signal of technical maturity and policy relevance.Unitree Robotics’ repeated appearances underscore this dynamic. The company has previously used the Gala to demonstrate improvements in motion control, balance and coordination, capabilities that are critical as robots move from laboratory environments into commercial and industrial settings. Its continued inclusion suggests confidence in its engineering progress and deployment readiness.Galbot’s designation as the Gala’s embodied large-model robot reflects a broader shift in focus from mechanical performance alone to systems that integrate perception, reasoning and physical execution. Embodied artificial intelligence—where large models are combined with real-world robotic interaction—has become a priority area for Chinese research institutions and technology companies as generative AI expands beyond software applications.The addition of Noetix Robotics introduces another layer to the lineup. The company concentrates on robotic power systems and core engineering components, segments that are increasingly viewed as strategic as China seeks to reduce reliance on imported technologies and strengthen domestic supply chains. Shoucheng Holdings’ sustained backing of Noetix Robotics highlights an investment strategy that spans both complete robotic systems and foundational hardware.Shoucheng Holdings has steadily increased its exposure to robotics over the past several years, backing companies involved in full-stack robotics, embodied intelligence and critical components. Rather than focusing on a single technological approach, the firm has adopted a portfolio strategy that combines capital investment with access to application scenarios and commercialization platforms.One such platform is the Shoucheng Robot Tech Experience Store, a robotics-focused retail and demonstration network operated by the company. While not all Gala participants are Shoucheng investees, some companies, including MagicLab Robotics Technology (Wuxi) Co., Ltd., have placed products such as robotic dogs within the platform’s offline spaces for demonstrations and user engagement. MagicLab was named a strategic intelligent robotics partner for the Year of the Horse CMG New Year’s Gala earlier this year.By linking high-profile media exposure with physical demonstration and sales environments, Shoucheng Holdings aims to accelerate the transition from technology showcase to market adoption, according to people familiar with the platform’s positioning. The approach mirrors a broader trend among Chinese industrial investors to combine financial backing with scenario-based deployment.Industry analysts say the concentration of Shoucheng-backed companies on the 2026 Gala stage illustrates how China’s robotics sector is evolving from isolated prototypes toward more integrated industrial ecosystems. The presence of companies spanning full robotic platforms, embodied intelligence and core engineering components suggests increasing specialization and coordination across the value chain.As preparations for the 2026 CMG New Year’s Gala continue, robotics and artificial intelligence are expected to remain central themes. For Shoucheng Holdings, the event offers a snapshot of how its investments are converging on a national platform, reflecting a strategy that has shifted from selective bets to a broader, system-oriented approach to industrial technology.While the commercial impact of Gala exposure is difficult to quantify, market participants increasingly view the lineup as an indicator of which technologies and companies are gaining momentum within China’s rapidly changing AI and automation landscape. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – Quam Plus International Financial Limited ("Quam Plus Financial" or the "Group") is delighted to announce the successful conclusion of the "3rd Hong Kong Capital Markets Forum 2026" held at the Grand Hyatt Hong Kong. The Group is honored to be one of the Gold Sponsors of this prestigious event. Dr. Kenneth Lam, CEO of the Group, who also serves as Chairman of the Forum Organizing Committee cum Executive Deputy Chairman of The Chamber of Hong Kong Listed Companies (CHKLC), led a delegation of senior management to attend the forum. Mr. Paul Chan Mo-Po, GBM, GBS, MH, JP, Financial Secretary of the Government of HKSAR were also in attendance. Together with prominent figures from the capital markets, government, academia, and the financial sector, they engaged in in-depth discussions on further strengthening Hong Kong's economic momentum.The forum was jointly organized by Hong Kong Association of Registered Public Interest Entity Auditors Limited (PIEAA), The Chamber of Hong Kong Listed Companies (CHKLC), The Hong Kong Institute of Directors (HKIoD), and the Association of Hong Kong Capital Market Practitioners Limited (HKCMP), with strong support from key institutions including Hong Kong Exchanges and Clearing Limited (HKEX), the Securities and Futures Commission (SFC), and the Accounting and Financial Reporting Council (AFRC).As the global economy enters a new cycle of innovation and transformation, this year's forum, themed "Capturing the Next Growth Momentum” explored how Hong Kong can reinvent itself amid a rapidly changing international financial landscape, rebuild confidence, and transform challenges into powerful drivers of progress.As the globalMr. Paul Chan Mo-Po, GBM, GBS, MH, JP, served as the Guest of Honour and delivered the keynote address. He stated: "In my view, the global environment is shifting in ways that create new and favourable opportunities for Hong Kong. Our challenge is how to seize the moment and deliver tangible outcomes. More specifically, that involves supporting the country's high-quality development; matching the needs of Mainland enterprises going global and the appetite of international investors; and, at the same time, driving Hong Kong's own growth."Dr. Kenneth Lam, in his capacity as Chairman of the Forum Organizing Committee, delivered the opening remarks: "As a vital financial hub connecting China and the world, our mission is to strengthen confidence, deepen integration, and expand diverse growth engines. We must keenly identify the next wave of growth drivers and ensure that markets advance in a balanced manner between flexibility and integrity. Positioned at the core of global transformation, this forum reminds us once again that progress is never accidental—it stems from resolute choices: with innovation as our aspiration, collaboration as our bridge, and conviction as our strength, we can lead Hong Kong forward and open up new chapters."Hong Kong now stands at the heart of global change. Advancing the capital markets requires not only visionary policies and regulation but also active participation and collaboration from all sectors. This year's forum focused on two key themes—digital asset development and capital market structural reform—examining how technological innovation can coexist with trust to drive reforms that build greater market resilience.As a proud Gold Sponsor of this year's forum, Quam Plus Financial looks forward to working hand in hand with all stakeholders, including central government offices in Hong Kong and other parties, to propel Hong Kong and the region toward new achievements. Together, we aim to seize new opportunities, activate new momentum, and march toward a high-quality, sustainable financial future.About Quam Plus International Financial LimitedQuam Plus International Financial Limited (the “Company”, Stock Code: 00952.HK) is a Hong Kong based financial services group which is listed on the Main Board of the Stock Exchange of Hong Kong Limited. The Company was publicly listed in Hong Kong in 1997, it is committed to building a comprehensive, full-licensed integrated financial platform. The core businesses of the Company are brokerage business, interest income business, corporate finance business, asset management business and investments and other businesses. The Company strives to become the ideal partner for both corporate and individual investors in Hong Kong and China. The Company also offers premier one-stop financial services to its clients. The Company continued to provide capital markets services through its representative office or the wholly-owned foreign enterprise in Shenzhen, Shanghai, Shenyang, Ningbo, Beijing, Chengdu, Hangzhou and Xiamen of the PRC and through its networks of Global Alliance Partners network and Oaklins International.For further information, please contact:Quam IR LimitedMandy Lo Tel: (852) 2217-2753 Email: mandy.lo@quamgroup.comCharlie Chan Tel: (852) 2217-2504 Email: charlie.chan@quamgroup.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年1月30日 - (亚太商讯 via SeaPRwire.com) - 华富建业国际金融有限公司（下称「华富建业金融」或「集团」）欣然宣布，「第三届香港资本市场论坛2026」于香港君悦酒店圆满举行。集团非常荣幸成为本次论坛的黄金赞助商之一。公司行政总裁林建兴博士身兼香港资本市场论坛筹委会主席暨香港上市公司商会常务副主席，率领集团多位高级管理层出席盛会。香港特別行政區政府財政司司長陳茂波先生亦亲临出席，与来自资本市场、政府机构、学术界及金融行业的众多专业人士齐聚一堂，深入探讨如何进一步激发香港经济新动力。本届论坛由香港上市公司商会、香港董事学会及香港上市公司审核师协会有限公司及香港资本市场专业人员协会联合主办，获香港交易所、证券及期货事务监察委员会、会计及财务汇报局等机构大力支持。随着全球经济进入创新与变革的新周期，本届论坛以「瞄准新机遇 启动新引擎」为主题，聚焦香港如何在瞬息万变的国际金融格局中开创新局、重振信心，并将挑战转化为持续进步的强大动力。陈茂波先生担任主礼嘉宾，并在致辞中指出：「全球环境正以新的方式转变，为香港带来崭新而有利的机遇。我们面临的挑战，是如何把握时机，并交付具体而实在的成果。更具体而言，这包括支持国家的高质量发展；衔接内地企业走出去的需求与国际投资者的投资意向，同时推动香港自身的发展。」林建兴博士以论坛筹委会主席身份发表开幕致辞，他表示：「作为连系中国与世界的重要金融枢纽，我们的使命是强化市场信心、深化融合发展、拓展多元增长引擎。我们须准确洞察新一轮增长动能，确保市场在灵活创新与稳健诚信之间实现协调共进。香港正站在全球变革的核心位置，本届论坛再次提醒我们：进步从来不是偶然，而是源于坚定抉择——以创新为志、以协作为桥、以信念为力，方能引领香港持续前行，共创新猷。」当前，香港处于全球变革的核心位置，推动资本市场进步不仅依赖政策与监管的远见，更需各界积极参与及深度协作。本届论坛聚焦数字资产发展及资本市场结构变革两大主题，探讨科技创新如何与市场信任并行，助力改革步伐塑造更强韧性的市场生态。华富建业金融作为本届论坛的黄金赞助商，深感荣幸。集团期望携手社会各界，群策群力，共同推动香港资本市场与区域经济共创辉煌、再谱新章，瞄准新机遇、启动新引擎，迈向高质量、可持续的金融未来。关于华富建业国际金融有限公司 华富建业国际金融有限公司(「本公司」，股份代号: 00952.HK)，为香港联合交易所有限公司的主板上市公司，是一家以香港为基地的金融服务机构。本集团于 1997 年在香港上市，致力打造成为全方位，全牌照的综合性金融平台。公司主要业务包括经纪业务、利息收入业务、企业融资业务、资产管理业务和投资及其他业务。本公司致力成为香港及中国企业与个人投资者的理想金融服务伙伴，并为客户提供卓越的一站式财经服务。本公司并透过中国深圳、上海、沈阳、宁波、北京、成都、杭州及厦门的代表处或全资拥有的外资企业，以及透过 Global Alliance Partners 及 Oaklins International 的网络及成员，为客户提供资本市场服务。如有垂询，请联系：华富投资者关系有限公司卢秋玲 (Mandy Lo) 电话：(852) 2217-2753 电邮：mandy.lo@quamgroup.com陈碧虹 (Charlie Chan) 电话：(852) 2217-2504 电邮：charlie.chan@quamgroup.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com